<?xml version="1.0" encoding="UTF-8"?>
<p>CQ was shown to inhibit the in vitro replication of H1N1 and H3N2 IAV strains [
 <xref rid="B159-microorganisms-08-00085" ref-type="bibr">159</xref>]. A phase II clinical trial aiming to verify the effect of CQ compared to that of placebo on IAV was started in Singapore in 2005, and 1516 patients were recruited. However, CQ was not shown to prevent infection with IAV (
 <xref rid="microorganisms-08-00085-t001" ref-type="table">Table 1</xref>) [
 <xref rid="B38-microorganisms-08-00085" ref-type="bibr">38</xref>].
</p>
